GlassScriptPhysician profile
Steven D Cowles
NPI 1427436559
$391.12
in general payments reported to CMS, 2019-2025
16 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.34 · 2020: $35.91 · 2021: $70.75 · 2022: $68.92 · 2023: $17.58 · 2024: $11.46 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $71.69 | 2021-2025 | Slynd |
| Organon LLC | $67.08 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $34.42 | 2019-2020 | |
| Agile Therapeutics, INC. | $24.36 | 2021 | |
| Mallinckrodt Hospital Products INC. | $22.83 | 2020 | |
| Coloplast Corp | $20.79 | 2025 | |
| Coopersurgical, INC. | $19.18 | 2025 | Sos |
| Hologic Sales and Service, LLC | $17.97 | 2025 | Myosure Tissue Removal Device |
| Abbvie INC. | $17.27 | 2025 | |
| Sumitomo Pharma America, INC. | $16.59 | 2025 | Myfembree |
| Biogen, INC. | $15.25 | 2025 | Zurzuvae |
| Roche Diagnostics Corporation | $15.15 | 2021 | |
| Daiichi Sankyo INC. | $14.09 | 2021 | |
| Avion Pharmaceuticals | $12.69 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.78 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $9.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.